OutSee
To add a bio or update company history, please click update information.
News from OutSee
OutSee
24 Jun 2025
OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.
OutSee
12 Jan 2026
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.
OutSee
- Life Sciences
- Cambridge, United Kingdom
- £4.3m
- outsee.co.uk
- Update Information
More venture news
- 5 Aug 2026
MironidMironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Series BLife Sciences - 29 Jul 2026
QureightQureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
Series BLife Sciences - 7 Jul 2026
Healome TherapeuticsHealome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
SeedLife Sciences